Fecal Microbiota Transplantation as a Rescue Therapy for Refractory Clostridioides difficile Infection in a Patient With Lupus
Open Access
- 1 January 2026
- journal article
- Published by Wiley in Case Reports in Infectious Diseases
- Vol. 2026 (1) , 7694915
Abstract
Clostridioides difficile infection (CDI) remains a major clinical challenge, particularly when it is refractory or recurrent. We describe a 68‐year‐old woman with systemic lupus erythematosus and other comorbidities who developed fulminant refractory CDI, characterized by ileus and persistent symptoms despite a course of oral vancomycin. She presented with abdominal pain, bilious vomiting, and high‐volume diarrhea. Stool testing detected C. difficile toxins A and B, and imaging showed bowel dilatation, mucosal thickening, and lymphadenopathy. Despite 18 days of oral vancomycin and intravenous metronidazole, she showed no clinical improvement. A single fecal microbiota transplantation (FMT) was therefore performed as rescue therapy. Diarrhea resolved completely within 3 days, with no CDI recurrence or FMT‐related adverse events during 12 months of follow‐up. This case illustrates the potential role of FMT as rescue therapy for fulminant refractory CDI in selected immunocompromised patients. Careful donor screening and close clinical monitoring remain essential, and further research is needed to define the long‐term safety of FMT in patients with autoimmune diseases.Keywords
This publication has 11 references indexed in Scilit:
- Major Systemic Lupus Erythematosus Exacerbation after Severe Clostridium Difficile Infection: A Case ReportMediterranean Journal of Rheumatology, 2024
- Fecal Microbiota Transplantation: A Systematic Review of Therapeutic Potential, Preparation Techniques, and Delivery Methods Across Medical ConditionsKurdistan Journal of Applied Research, 2024
- AGA Clinical Practice Guideline on Fecal Microbiota–Based Therapies for Select Gastrointestinal DiseasesGastroenterology, 2024
- S226 Inpatient Outcomes of Clostridioides difficile Infection Among Patients With and Without Systemic Lupus ErythematosusAmerican Journal of Gastroenterology, 2021
- Fecal Microbiota Transplantation: Redefining Surgical Management of Refractory Clostridium difficile InfectionClinics in Colon and Rectal Surgery, 2020
- International consensus conference on stool banking for faecal microbiota transplantation in clinical practiceGut, 2019
- Successful treatment by fecal microbiota transplantation for Japanese patients with refractory Clostridium difficile infection: A prospective case seriesJournal of Microbiology, Immunology and Infection, 2019
- Fecal microbiota transplantation in the treatment of Clostridium difficile infection: state of the art and literature review.Revista do Colégio Brasileiro de Cirurgiões, 2018
- Clostridium difficile Infection and Fecal Microbiota TransplantAACN Advanced Critical Care, 2016
- Fecal Microbiota Transplantation for Treatment of Severe, Recurrent, and Refractory Clostridium difficile Infection in a Severely Immunocompromised PatientInfectious Diseases in Clinical Practice, 2016